PT Kimia Farma TbkISX:KAEF 56 Quick Ratio is 0.46 as of Mar. 2026, which is 22% below its 10-year median of 0.59. GuruFocus rates ISX:KAEF with a GF Score™ of 56/100 and a GF Value™ of Rp581.83 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 118 Medical Distribution companies, PT Kimia Farma Tbk ranks worse than 95.76% on this metric.
PT Kimia Farma Tbk has a quick ratio of 0.46. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for PT Kimia Farma Tbk's Quick Ratio or its related term are showing as below:
ISX:KAEF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.59 Max: 1.25
Current: 0.46
During the past 13 years, PT Kimia Farma Tbk's highest Quick Ratio was 1.25. The lowest was 0.29. And the median was 0.59.
ISX:KAEF's Quick Ratio is ranked worse than 95.76% of 118
companies
in the Medical Distribution industry
Industry Median: 1.05
vs ISX:KAEF: 0.46
PT Kimia Farma Tbk (ISX:KAEF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
PT Kimia Farma Tbk Quick Ratio Related Terms
PT Kimia Farma Tbk Quick Ratio Historical Data
* Premium members only.
The historical data trend for PT Kimia Farma Tbk's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Kimia Farma Tbk's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Tbk Quick Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Quick Ratio distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Tbk's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
PT Kimia Farma Tbk's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Tbk (ISX:KAEF) has a Quick Ratio of 0.46 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PT Kimia Farma Tbk and its competitors. This is 22% below median its historical median of 0.59. Over the past decade, PT Kimia Farma Tbk's Quick Ratio has ranged from 0.29 to 1.25. According to the industry distribution chart, PT Kimia Farma Tbk ranks #113 out of 118 companies in the Medical Distribution industry, placing it in the top 95.8%.
Is PT Kimia Farma Tbk's Quick Ratio too high?
PT Kimia Farma Tbk's current Quick Ratio of 0.46 is 22% below median its 10-year median of 0.59. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 1.25. The Medical Distribution industry median Quick Ratio is 1.05. PT Kimia Farma Tbk's value of 0.46 is 56.2% below this industry median. Based on the distribution chart, PT Kimia Farma Tbk ranks #113 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, PT Kimia Farma Tbk has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Tbk's Quick Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Tbk ranks #113 out of 118 companies for Quick Ratio. This places PT Kimia Farma Tbk in the lower half of its industry. The industry median Quick Ratio is 1.05. PT Kimia Farma Tbk's value of 0.46 is 56.2% below this benchmark. Historically, PT Kimia Farma Tbk's own Quick Ratio has ranged from 0.29 to 1.25 over the past decade. While the company's 10-year median is 0.59 vs. the industry median of 1.05, PT Kimia Farma Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Distribution company?
The median Quick Ratio among Medical Distribution companies is 1.05, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Kimia Farma Tbk's current Quick Ratio of 0.46 is 56.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PT Kimia Farma Tbk and its competitors. For the Medical Distribution industry, the median Quick Ratio is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Tbk's current Quick Ratio is 0.46, which is 22% below median its own 10-year median of 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp581.83, compared to a current price of Rp420.00 — trading 27.8% below its estimated fair value. The current Quick Ratio is 0.46, which is 22% below median its 10-year median of 0.59 and 56.2% below the Medical Distribution industry median of 1.05. PT Kimia Farma Tbk's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For PT Kimia Farma Tbk (ISX:KAEF), the current Quick Ratio is 0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Tbk stock appears to be undervalued.
The current stock price of Rp420.00 is trading 27.8% below its estimated GF Value™ of Rp581.83.
GuruFocus considers PT Kimia Farma Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
Quick Ratio: 0.46 (22% below median its 10-year median of 0.59)
GF Value™: Rp581.83 vs. price of Rp420.00 (27.8% below fair value)
Industry Position: 56.2% below the Medical Distribution median (#113 of 118)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
56GF Score
Get the complete analysis for ISX:KAEF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
